...
首页> 外文期刊>Mediterranean Journal of Hematology and Infectious Diseases >BONE MARROW HOMING AND ENGRAFTMENT DEFECTS OF HUMAN HEMATOPOIETIC STEM AND PROGENITOR CELLS
【24h】

BONE MARROW HOMING AND ENGRAFTMENT DEFECTS OF HUMAN HEMATOPOIETIC STEM AND PROGENITOR CELLS

机译:人体造血干细胞和祖细胞的骨骨髓归巢和移植缺陷

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Homing of hematopoietic stem cells (HSC) to their microenvironment niches in the bone marrow is a complex process with a critical role in repopulation of the bone marrow after transplantation. This active process allows for migration of HSC from peripheral blood and their successful anchoring in bone marrow before proliferation. The process of engraftment starts with the onset of proliferation and must therefore be functionally dissociated from the former process. In this overview we analyse the characteristics of stem cells (SCs) with particular emphasis on their plasticity and ability to find their way home to the bone marrow. We also address the problem of graft failure which remains an important contributor to morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). Within this context, we discuss non-malignant and malignant hematological disorders treated with reduced intensity conditioning regimens or grafts from human leukocyte antigen (HLA)-mismatched donors.
机译:将造血干细胞(HSC)归巢到骨髓中的微环境壁ni是一个复杂的过程,在移植后的骨髓再生中起着至关重要的作用。这种活跃的过程允许HSC从外周血迁移,并在增殖之前将其成功锚定在骨髓中。植入过程始于增殖的开始,因此必须在功能上与前一过程分离。在本概述中,我们分析了干细胞(SCs)的特征,特别着重于它们的可塑性和找到其回家之路的能力。我们还解决了移植失败的问题,该问题仍然是异基因造血干细胞移植(HSCT)后发病率和死亡率的重要因素。在这种情况下,我们讨论了用降低强度调节方案或人类白细胞抗原(HLA)不匹配供体的移植物治疗的非恶性和恶性血液病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号